From:  Therapeutic targets for metabolic dysfunction-associated steatotic liver disease and their roles in hepatocellular carcinoma

Related drugs targeting PPARβ/δ

PPARβ/δ agonistsAliasMolecular formulaChemical structureR & D stageReferences
SeladelparMBX-8025, RWJ-800025C21H23F3O5SPhase III[44]
ElafibranorUSAN, 2J3H5C81A5, GFT-505C22H24O4SPhase III[44]
LanifibranorIVA-337C19H15ClN2O4S2Phase III[45]
KD-3010KD3010C30H33F3N2O8S2Phase I[46]
Return to article view